Aleksey A. Rybalov
Head of Department at Izvarino Pharma LLC, ORCID: https://orcid.org/0009-0002-6807-069X
Author's articles:
REVIEW OF CLINICAL TRIALS OF PROMISING BISPECIFIC CANDIDATES FOR CAR-T CELL THERAPY
 Background: CAR-T (Chimeric Antigen Receptor T-Cell) therapy has proven to be highly effective in the treatment of ...